{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:23:01Z","timestamp":1793499781197,"version":"4.5.0"},"reference-count":109,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MSD for Mothers","award":["MFM-22-159697"],"award-info":[{"award-number":["MFM-22-159697"]}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE200100264"],"award-info":[{"award-number":["DE200100264"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","award":["Dame Kate Campbell Fellowship"],"award-info":[{"award-number":["Dame Kate Campbell Fellowship"]}],"id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194248"],"award-info":[{"award-number":["GNT1194248"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Poor representation of pregnant and lactating women and people in clinical trials has marginalised their health concerns and denied the maternal\u2013fetal\/infant dyad benefits of innovation in therapeutic research and development. This mixed-methods systematic review synthesised factors affecting the participation of pregnant and lactating women in clinical trials, across all levels of the research ecosystem.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We searched 8 databases from inception to 14 February 2024 to identify qualitative, quantitative, and mixed-methods studies that described factors affecting participation of pregnant and lactating women in vaccine and therapeutic clinical trials in any setting. We used thematic synthesis to analyse the qualitative literature and assessed confidence in each qualitative review finding using the GRADE-CERQual approach. We compared quantitative data against the thematic synthesis findings to assess areas of convergence or divergence. We mapped review findings to the Theoretical Domains Framework (TDF) and Capability, Opportunity, and Motivation Model of Behaviour (COM-B) to inform future development of behaviour change strategies.<\/jats:p>\n<jats:p>We included 60 papers from 27 countries. We grouped 24 review findings under 5 overarching themes: (a) interplay between perceived risks and benefits of participation in women\u2019s decision-making; (b) engagement between women and the medical and research ecosystems; (c) gender norms and decision-making autonomy; (d) factors affecting clinical trial recruitment; and (e) upstream factors in the research ecosystem. Women\u2019s willingness to participate in trials was affected by: perceived risk of the health condition weighed against an intervention\u2019s risks and benefits, therapeutic optimism, intervention acceptability, expectations of receiving higher quality care in a trial, altruistic motivations, intimate relationship dynamics, and power and trust in medicine and research. Health workers supported women\u2019s participation in trials when they perceived clinical equipoise, had hope for novel therapeutic applications, and were convinced an intervention was safe. For research staff, developing reciprocal relationships with health workers, having access to resources for trial implementation, ensuring the trial was visible to potential participants and health workers, implementing a woman-centred approach when communicating with potential participants, and emotional orientations towards the trial were factors perceived to affect recruitment. For study investigators and ethics committees, the complexities and subjectivities in risk assessments and trial design, and limited funding of such trials contributed to their reluctance in leading and approving such trials. All included studies focused on factors affecting participation of cisgender pregnant women in clinical trials; future research should consider other pregnancy-capable populations, including transgender and nonbinary people.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This systematic review highlights diverse factors across multiple levels and stakeholders affecting the participation of pregnant and lactating women in clinical trials. By linking identified factors to frameworks of behaviour change, we have developed theoretically informed strategies that can help optimise pregnant and lactating women\u2019s engagement, participation, and trust in such trials.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004405","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:42:57Z","timestamp":1717090977000},"page":"e1004405","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-6396","authenticated-orcid":true,"given":"Mridula","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya","family":"Hazfiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-2336","authenticated-orcid":true,"given":"Rana Islamiah","family":"Zahroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-7096","authenticated-orcid":true,"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-6679","authenticated-orcid":true,"given":"Annie R. A.","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-8328","authenticated-orcid":true,"given":"Patrick","family":"Condron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-7053","authenticated-orcid":true,"given":"Shivaprasad S.","family":"Goudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-9849","authenticated-orcid":true,"given":"Yeshita V.","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8871-5072","authenticated-orcid":true,"given":"Manjunath S.","family":"Somannavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-2798","authenticated-orcid":true,"given":"Umesh","family":"Charantimath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1059-061X","authenticated-orcid":true,"given":"Anne","family":"Ammerdorffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-4955","authenticated-orcid":true,"given":"Sara","family":"Rushwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-0998","authenticated-orcid":true,"given":"A. Metin","family":"G\u00fclmezoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-4682","authenticated-orcid":true,"given":"Meghan A.","family":"Bohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"1","key":"pmed.1004405.ref001","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1471-0528.14151","article-title":"The pregnant women as a drug orphan: A global survey of registered clinical trials of pharmacological interventions in pregnancy","volume":"124","author":"J Scaffidi","year":"2017","journal-title":"BJOG"},{"issue":"1","key":"pmed.1004405.ref002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajog.2021.04.227","article-title":"Drug development research in pregnant and lactating women","volume":"225","author":"Z Ren","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"pmed.1004405.ref003","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0b013e3182a9ca67","article-title":"Exclusion of pregnant women from industry-sponsored clinical trials","volume":"122","author":"KE Shields","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"pmed.1004405.ref004","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.medj.2021.04.019","article-title":"Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US","volume":"2","author":"EF Jaffe","year":"2021","journal-title":"Med"},{"issue":"11","key":"pmed.1004405.ref005","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.2021.2264","article-title":"Pregnant people\u2019s paradox-excluded from vaccine trials despite having a higher risk of COVID-19 complications","volume":"325","author":"R. Rubin","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"pmed.1004405.ref006","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","article-title":"Inclusion of pregnant women in COVID-19 treatment trials: A review and global call to action","volume":"9","author":"MM Taylor","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"7","key":"pmed.1004405.ref007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/AOG.0000000000003924","article-title":"Protection by exclusion: Another missed opportunity to include pregnant women in research during the coronavirus disease 2019 (COVID-19) pandemic","volume":"161","author":"MM Costantine","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"9","key":"pmed.1004405.ref008","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1473-3099(20)30638-1","article-title":"Inclusion of pregnant women in COVID-19 vaccine development","volume":"20","author":"PT Heath","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"pmed.1004405.ref009","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M20-3106","article-title":"The moral imperative to include pregnant women in clinical trials of interventions for COVID-19","volume":"173","author":"I Malhame","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7","key":"pmed.1004405.ref010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"M Feghali","year":"2015","journal-title":"Semin Perinatol"},{"issue":"1","key":"pmed.1004405.ref011","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: Issues in clinical research","volume":"23","author":"MC Blehar","year":"2013","journal-title":"Womens Health Issues"},{"key":"pmed.1004405.ref012","unstructured":"Task Force on Research Specific to Pregnant Women and Lactating Women. Report to Secretary, Health and Human Services, Congress. 2018. Available from: https:\/\/www.nichd.nih.gov\/sites\/default\/files\/2018-09\/PRGLAC_Report.pdf."},{"key":"pmed.1004405.ref013","unstructured":"World Health Organization. Trends in maternal mortality 2000 to 2020: Estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division. Geneva: World Health Organization; 2023. 9240069259."},{"key":"pmed.1004405.ref014","volume-title":"Never forgotten\u2013the situation of stillbirth around the globe","author":"UN Inter-agency Group for Child Mortality Estimation","year":"2023"},{"key":"pmed.1004405.ref015","volume-title":"Levels and trends in child mortality: Report 2022 estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation","author":"UN Inter-agency Group for Child Mortality Estimation","year":"2023"},{"issue":"1","key":"pmed.1004405.ref016","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0050022","article-title":"Market failure and the poverty of new drugs in maternal health","volume":"5","author":"NM Fisk","year":"2008","journal-title":"PLoS Med"},{"key":"pmed.1004405.ref017","volume-title":"Safe and effective medicines for use in pregnancy: A call to action","author":"S Bhattacharya","year":"2021"},{"key":"pmed.1004405.ref018","volume-title":"Market challenges and potential solutions for the development and introduction of medicines for pregnancy specific conditions","author":"Concept Foundation","year":"2021"},{"issue":"6","key":"pmed.1004405.ref019","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-3156.2011.02778.x","article-title":"Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D","volume":"16","author":"NM Fisk","year":"2011","journal-title":"Trop Med Int Health"},{"key":"pmed.1004405.ref020","volume-title":"Transforming our world: The 2030 Agenda for Sustainable Development.","author":"U. N. General Assembly","year":"2015"},{"issue":"1","key":"pmed.1004405.ref021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13063-017-2402-9","article-title":"Fair inclusion of pregnant women in clinical trials: An integrated scientific and ethical approach","volume":"19","author":"R van der Graaf","year":"2018","journal-title":"Trials"},{"issue":"S1","key":"pmed.1004405.ref022","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/jcph.2124","article-title":"Maternal-fetal drug development: An industry perspective","volume":"62","author":"J Burnham","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"pmed.1004405.ref023","doi-asserted-by":"crossref","first-page":"e071278","DOI":"10.1136\/bmj-2022-071278","article-title":"Facilitating participation in clinical trials during pregnancy","volume":"380","author":"N Vousden","year":"2023","journal-title":"BMJ"},{"issue":"1","key":"pmed.1004405.ref024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"L Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"pmed.1004405.ref025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"S Michie","year":"2011","journal-title":"Implement Sci"},{"key":"pmed.1004405.ref026","article-title":"Cochrane qualitative evidence synthesis: Protocol and review template. Version 1.4b","author":"C Glenton","year":"2023","journal-title":"Cochrane Person Centred Care, Health Systems and Public Health and Cochrane Norway"},{"key":"pmed.1004405.ref027","unstructured":"Veritas Health Innovation. Covidence systematic review software [internet]. 2023."},{"key":"pmed.1004405.ref028","unstructured":"OpenAI. Chatgpt. 2023."},{"key":"pmed.1004405.ref029","author":"QN Hong","year":"2018"},{"key":"pmed.1004405.ref030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"J Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"pmed.1004405.ref031","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/heapol\/czab149","article-title":"Using gender analysis matrixes to integrate a gender lens into infectious diseases outbreaks research","volume":"37","author":"R Morgan","year":"2022","journal-title":"Health Policy Plan"},{"issue":"Suppl 1","key":"pmed.1004405.ref032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13012-017-0689-2","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 2: How to make an overall CERQual assessment of confidence and create a Summary of Qualitative Findings table","volume":"13","author":"S Lewin","year":"2018","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"pmed.1004405.ref033","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13012-017-0688-3","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings: Introduction to the series","volume":"13","author":"S Lewin","year":"2018","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"pmed.1004405.ref034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13012-017-0690-9","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 3: How to assess methodological limitations","volume":"13","author":"H Munthe-Kaas","year":"2018","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"pmed.1004405.ref035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13012-017-0691-8","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 4: How to assess coherence","volume":"13","author":"CJ Colvin","year":"2018","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"pmed.1004405.ref036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13012-017-0692-7","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 5: How to assess adequacy of data","volume":"13","author":"C Glenton","year":"2018","journal-title":"Implement Sci"},{"issue":"Suppl 1","key":"pmed.1004405.ref037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13012-017-0693-6","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 6: How to assess relevance of the data","volume":"13","author":"J Noyes","year":"2018","journal-title":"Implement Sci"},{"issue":"101754913","key":"pmed.1004405.ref038","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12688\/hrbopenres.12811.1","article-title":"Assessment of the understanding of informed consent including participants\u2019 experiences, and generation of a supplemental consent decision aid for gestational diabetes mellitus (GDM) research","volume":"1","author":"S Atal","year":"2018","journal-title":"HRB Open Res"},{"issue":"1","key":"pmed.1004405.ref039","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0730-7659.2005.00346.x","article-title":"Factors that influence women\u2019s decisions about whether to participate in research: An exploratory study","volume":"32","author":"L Baker","year":"2005","journal-title":"Birth"},{"issue":"6","key":"pmed.1004405.ref040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bioe.12361","article-title":"The experiences of pregnant women in an interventional clinical trial: Research In Pregnancy Ethics (RIPE) study","volume":"31","author":"A Ballantyne","year":"2017","journal-title":"Bioethics"},{"issue":"11","key":"pmed.1004405.ref041","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/INF.0000000000004036","article-title":"A questionnaire-based study exploring participant perspectives in a perinatal human challenge trial","volume":"42","author":"JH Bevan","year":"2023","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"pmed.1004405.ref042","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/21507716.2011.561517","article-title":"Ethical barriers to perinatal mental health research and evidence-based treatment: An empirical study","volume":"2","author":"AR Brandon","year":"2011","journal-title":"AJOB Prim Res"},{"issue":"2","key":"pmed.1004405.ref043","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/23294515.2013.851128","article-title":"Ethical challenges in designing, conducting, and reporting research to improve the mental health of pregnant women: The voices of investigators and irb members","volume":"5","author":"AR Brandon","year":"2014","journal-title":"AJOB Empir Bioethics"},{"issue":"425","key":"pmed.1004405.ref044","article-title":"Fear and rumours regarding placental biopsies in a malaria-in-pregnancy trial in Benin","volume":"17","author":"A Compaore","year":"2018","journal-title":"Malar J"},{"issue":"1","key":"pmed.1004405.ref045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cct.2006.08.003","article-title":"Involving communities in the design of clinical trial protocols: The BAN Study in Lilongwe","volume":"28","author":"AL Corneli","year":"2007","journal-title":"Malawi Contemp Clin Trials"},{"issue":"8","key":"pmed.1004405.ref046","first-page":"343","article-title":"The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan. Participants\u2019 understanding of the trial principles","volume":"32","author":"D Coulibaly-Traore","year":"2003","journal-title":"Presse Med"},{"issue":"2","key":"pmed.1004405.ref047","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/dewb.12132","article-title":"Power difference and risk perception: Mapping vulnerability within the decision process of pregnant women towards clinical trial participation in an urban middle-income setting","volume":"18","author":"GC Den Hollander","year":"2018","journal-title":"Dev World Bioeth"},{"issue":"12","key":"pmed.1004405.ref048","doi-asserted-by":"crossref","first-page":"e073992","DOI":"10.1136\/bmjopen-2023-073992","article-title":"Qualitative interview study exploring the perspectives of pregnant women on participating in controlled human infection research in the UK","volume":"13","author":"RB Dorey","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"pmed.1004405.ref049","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/02646830050008369","article-title":"Testing a drug during labour: The experiences of women who participated in a clinical trial","volume":"18","author":"PR Ferguson","year":"2000","journal-title":"J Reprod Infant Psychol"},{"issue":"37","key":"pmed.1004405.ref050","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1016\/j.vaccine.2022.07.049","article-title":"Midwives\u2019 attitudes toward participation of pregnant individuals in a preventive vaccine hypothetical clinical trial","volume":"40","author":"A Gagneux-Brunon","year":"2022","journal-title":"Vaccine"},{"issue":"45","key":"pmed.1004405.ref051","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2018.09.042","article-title":"Pregnant women\u2019s attitudes toward Zika virus vaccine trial participation","volume":"36","author":"IT Goldfarb","year":"2018","journal-title":"Vaccine"},{"issue":"3\u20134","key":"pmed.1004405.ref052","first-page":"108","article-title":"Women\u2019s health care providers\u2019 attitudes toward research in pregnancy","volume":"55","author":"DM Haas","year":"2010","journal-title":"J Reprod Med"},{"issue":"1","key":"pmed.1004405.ref053","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13063-016-1394-1","article-title":"The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: Balancing hope and uncertainty","volume":"17","author":"N Hallowell","year":"2016","journal-title":"Trials"},{"key":"pmed.1004405.ref054","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2022.01.015","article-title":"Theory-guided interviews identified behavioral barriers and enablers to healthcare professionals recruiting participants to maternity trials: Behavioural factors influencing healthcare professionals recruiting to maternity care trials: Using the theoretic.","volume":"145","author":"V Hanrahan","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"pmed.1004405.ref055","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1016\/j.vaccine.2017.10.041","article-title":"Recruitment barriers for prophylactic vaccine trials: A study in Belgium","volume":"35","author":"L Harrington","year":"2017","journal-title":"Vaccine"},{"issue":"13","key":"pmed.1004405.ref056","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/1471-0528.15333","article-title":"What women think about consent to research at the time of an obstetric emergency: A qualitative study of the views of a cohort of World Maternal Antifibrinolytic Trial participants","volume":"125","author":"G Houghton","year":"2018","journal-title":"BJOG"},{"issue":"44","key":"pmed.1004405.ref057","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.vaccine.2020.08.059","article-title":"Pregnant women\u2019s perceptions of risks and benefits when considering participation in vaccine trials","volume":"38","author":"E Jaffe","year":"2020","journal-title":"Vaccine"},{"issue":"39","key":"pmed.1004405.ref058","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.vaccine.2021.07.099","article-title":"My primary purpose is to protect the unborn child\u2019: Understanding pregnant women\u2019s perceptions of maternal vaccination and vaccine trials in Europe","volume":"39","author":"E Karafillakis","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"pmed.1004405.ref059","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/qshc.2005.015636","article-title":"Participating in a trial in a critical situation: A qualitative study in pregnancy","volume":"15","author":"S Kenyon","year":"2006","journal-title":"Qual Saf Health Care"},{"issue":"2","key":"pmed.1004405.ref060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17470161211066159","article-title":"Motives and risk perceptions of participants in a phase 1 trial for Hepatitis C virus investigational therapy in pregnancy","volume":"18","author":"Y Kislovskiy","year":"2022","journal-title":"Res Ethics"},{"key":"pmed.1004405.ref061","first-page":"17","article-title":"Recruiting and consenting into a peripartum trial in an emergency setting: A qualitative study of the experiences and views of women and healthcare professionals","author":"J Lawton","year":"2016","journal-title":"Trials"},{"issue":"1","key":"pmed.1004405.ref062","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40814-022-01093-1","article-title":"Emesis in pregnancy\u2014a qualitative study on trial recruitment failure from the EMPOWER internal pilot.","volume":"8","author":"MLS Lie","year":"2022","journal-title":"Pilot Feasibility Stud"},{"issue":"4","key":"pmed.1004405.ref063","first-page":"1","article-title":"Women\u2019s views about participating in research while pregnant","volume":"34","author":"AD Lyerly","year":"2012","journal-title":"IRB"},{"issue":"20","key":"pmed.1004405.ref064","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182010717","article-title":"Acceptability of clinical trials on COVID-19 during pregnancy among pregnant women and healthcare providers: A qualitative study","volume":"18","author":"E Marban-Castro","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pmed.1004405.ref065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12936-018-2292-7","article-title":"Researchers have love for life\u2019: Opportunities and barriers to engage pregnant women in malaria research in post-Ebola Liberia","volume":"17","author":"G Martinez Perez","year":"2018","journal-title":"Malar J"},{"issue":"4","key":"pmed.1004405.ref066","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/eahr.500058","article-title":"The pathway forward: Insights on factors that facilitate research with pregnant women","volume":"42","author":"AC Mastroianni","year":"2020","journal-title":"Ethics Hum Res"},{"issue":"3","key":"pmed.1004405.ref067","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/aogs.13288","article-title":"Antenatal vaccination against Group B streptococcus: Attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation","volume":"97","author":"F McQuaid","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"pmed.1004405.ref068","doi-asserted-by":"crossref","first-page":"e010790","DOI":"10.1136\/bmjopen-2015-010790","article-title":"Factors influencing women\u2019s attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: An online survey","volume":"6","author":"F McQuaid","year":"2016","journal-title":"BMJ Open"},{"issue":"9","key":"pmed.1004405.ref069","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-0528.1999.tb08426.x","article-title":"Withholding consent to participate in clinical trials: Decisions of pregnant women","volume":"106","author":"K Mohanna","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"pmed.1004405.ref070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12884-019-2240-8","article-title":"Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: A qualitative analysis","volume":"19","author":"TM Monteiro","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"pmed.1004405.ref071","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/jwh.2017.6458","article-title":"A multicenter investigation of factors influencing women\u2019s participation in clinical trials.","volume":"27","author":"S Myles","year":"2018","journal-title":"J Women\u2019s Health"},{"issue":"12","key":"pmed.1004405.ref072","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pd.5554","article-title":"Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high risk of preterm pre-eclampsia","volume":"39","author":"AV Nikcevic","year":"2019","journal-title":"Prenat Diagn"},{"issue":"6","key":"pmed.1004405.ref073","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/trstmh\/traa120","article-title":"Participation of Ghanaian pregnant women in an antimalarial drug trial: Willingness, experiences and perceptions","volume":"115","author":"J Osarfo","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"100967799","key":"pmed.1004405.ref074","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12884-015-0641-x","article-title":"Pregnant womens\u2019 concerns when invited to a randomized trial: A qualitative case control study","volume":"15","author":"K Oude Rengerink","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"pmed.1004405.ref075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jogc.2016.04.100","article-title":"Optimizing participation of pregnant women in clinical trials: Factors influencing decisions about participation in medication and vaccine trials","volume":"38","author":"S Palmer","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"pmed.1004405.ref076","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1479-828X.2011.01341.x","article-title":"The ethics of obtaining consent in labour for research.","volume":"51","author":"R Reid","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"pmed.1004405.ref077","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2003-38318","article-title":"Participation of pregnant women in clinical trials: Will they participate and why?","volume":"20","author":"MA Rodger","year":"2003","journal-title":"Am J Perinatol"},{"issue":"101517926","key":"pmed.1004405.ref078","first-page":"242","article-title":"The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: A qualitative assessment of sub-Sahara Africa investigators\u2019 perception","volume":"41","author":"KA Salami","year":"2022","journal-title":"Pan Afr Med J"},{"key":"pmed.1004405.ref079","first-page":"1","article-title":"Motivations and demographic differences in pregnant individuals in the decision to participate in research","author":"TA Scott","year":"2023","journal-title":"Can J Anaesth"},{"issue":"3","key":"pmed.1004405.ref080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1523-536X.2009.00326.x","article-title":"Women\u2019s experiences of participating in the Magpie Trial: A postal survey in the United Kingdom","volume":"36","author":"RMD Smyth","year":"2009","journal-title":"Birth"},{"issue":"4","key":"pmed.1004405.ref081","first-page":"E478","article-title":"Deciding to join a perinatal randomised controlled trial: Experiences and views of pregnant women enroled in the Magpie Trial","volume":"28","author":"RMD Smyth","year":"2012","journal-title":"Midwifery"},{"issue":"6","key":"pmed.1004405.ref082","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.midw.2011.11.009","article-title":"Views of emergency research (VERA): A qualitative study of women and their partners\u2019 views of recruitment to trials in severe postpartum haemorrhage","volume":"28","author":"C Snowdon","year":"2012","journal-title":"Midwifery"},{"key":"pmed.1004405.ref083","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.socscimed.2018.01.014","article-title":"Improving recruitment to clinical trials during pregnancy: A mixed methods investigation","volume":"200","author":"S Strommer","year":"2018","journal-title":"Soc Sci Med"},{"issue":"1","key":"pmed.1004405.ref084","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12981-020-00271-6","article-title":"Views among Malawian women about joining HIV prevention clinical trials when pregnant","volume":"17","author":"K Sullivan","year":"2020","journal-title":"AIDS Res Therapy"},{"issue":"4","key":"pmed.1004405.ref085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1556264618783834","article-title":"Women\u2019s views about a paternal consent requirement for biomedical research in pregnancy","volume":"13","author":"KA Sullivan","year":"2018","journal-title":"J Empir Res Hum Res Ethics"},{"key":"pmed.1004405.ref086","first-page":"12","article-title":"Deferred consent in emergency obstetric research: Findings from qualitative interviews with women and recruiters in the ACROBAT pilot trial for severe postpartum haemorrhage","author":"L Sweeney","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"pmed.1004405.ref087","doi-asserted-by":"crossref","first-page":"e13930","DOI":"10.1111\/hex.13930","article-title":"Pregnant women with diabetes and their clinician\u2019s experience of participating in a pilot randomised controlled trial of corticosteroid administration in late pregnancy: A qualitative study","volume":"27","author":"L Sweet","year":"2024","journal-title":"Health Expect"},{"issue":"6","key":"pmed.1004405.ref088","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/eahr.500107","article-title":"Physician perspectives on including pregnant women in covid-19 clinical trials: Time for a paradigm change","volume":"43","author":"M-J Trahan","year":"2021","journal-title":"Ethics Hum Res"},{"issue":"1","key":"pmed.1004405.ref089","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12910-017-0194-9","article-title":"A qualitative study on acceptable levels of risk for pregnant women in clinical research","volume":"18","author":"ISE van der Zande","year":"2017","journal-title":"BMC Med Ethics"},{"issue":"1","key":"pmed.1004405.ref090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12884-019-2209-7","article-title":"A qualitative study on stakeholders\u2019 views on the participation of pregnant women in the APOSTEL VI study: A low-risk obstetrical RCT","volume":"19","author":"ISE van der Zande","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"13","key":"pmed.1004405.ref091","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1177\/1049732318773724","article-title":"Clinical research with pregnant women: Perspectives of pregnant women, health care providers, and researchers","volume":"28","author":"K Wada","year":"2018","journal-title":"Qual Health Res"},{"issue":"101754913","key":"pmed.1004405.ref092","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12688\/hrbopenres.13289.1","article-title":"Participation in a randomised controlled trial (RCT) of metformin in gestational diabetes mellitus (GDM): Pregnant women\u2019s perceptions and experiences of the decision-making process","volume":"4","author":"S Wallace","year":"2021","journal-title":"HRB Open Res"},{"issue":"5","key":"pmed.1004405.ref093","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/eahr.500100","article-title":"IRB decision-making about minimal risk research with pregnant participants","volume":"43","author":"A White","year":"2021","journal-title":"Ethics Hum Res"},{"issue":"9","key":"pmed.1004405.ref094","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000002384","article-title":"Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against Respiratory Syncytial Virus: A multicenter questionnaire study","volume":"38","author":"CR Wilcox","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"pmed.1004405.ref095","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1017\/cts.2022.476","article-title":"Peripartum women\u2019s perspectives on research study participation in the OneFlorida Clinical Research Consortium during COVID-19 pandemic","volume":"7","author":"K Xu","year":"2023","journal-title":"J Clin Transl Sci"},{"issue":"6","key":"pmed.1004405.ref096","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11096-018-0734-5","article-title":"Factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants: A qualitative study","volume":"40","author":"Y Zhao","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"101475748","key":"pmed.1004405.ref097","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2147\/PPA.S328969","article-title":"Clinical drug trial participation: Perspectives of pregnant women and their spouses","volume":"15","author":"Y Zhao","year":"2021","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"pmed.1004405.ref098","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.wombi.2017.12.009","article-title":"Facilitators and barriers to pregnant women\u2019s participation in research: A systematic review","volume":"31","author":"ISE van der Zande","year":"2018","journal-title":"Women Birth"},{"key":"pmed.1004405.ref099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-11-31","article-title":"Reasons for participating in randomised controlled trials: Conditional altruism and considerations for self","volume":"11","author":"SK McCann","year":"2010","journal-title":"Trials"},{"issue":"2","key":"pmed.1004405.ref100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(06)70576-9","article-title":"Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors","volume":"7","author":"EJ Mills","year":"2006","journal-title":"Lancet Oncol"},{"key":"pmed.1004405.ref101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1476-5","article-title":"The research burden of randomized controlled trial participation: A systematic thematic synthesis of qualitative evidence","volume":"18","author":"N Naidoo","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"pmed.1004405.ref102","doi-asserted-by":"crossref","first-page":"e0228063","DOI":"10.1371\/journal.pone.0228063","article-title":"Would you like to participate in this trial? The practice of informed consent in intrapartum research in the last 30 years","volume":"15","author":"M Widmer","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"pmed.1004405.ref103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12910-019-0363-0","article-title":"Ethical tensions in the informed consent process for randomized clinical trials in emergency obstetric and newborn care in low and middle-income countries","volume":"20","author":"DK Kaye","year":"2019","journal-title":"BMC Med Ethics"},{"issue":"1","key":"pmed.1004405.ref104","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12913-018-3399-9","article-title":"Clinicians\u2019 perspectives on and interest in participating in a clinical data research network across the Southeastern United States","volume":"18","author":"KM Unertl","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"pmed.1004405.ref105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/AMEP.S14103","article-title":"Physician participation in clinical research and trials: Issues and approaches","volume":"2","author":"S Rahman","year":"2011","journal-title":"Adv Med Educ Pract"},{"issue":"7","key":"pmed.1004405.ref106","doi-asserted-by":"crossref","first-page":"e059473","DOI":"10.1136\/bmjopen-2021-059473","article-title":"Randomised trials in maternal and perinatal health in low and middle-income countries from 2010 to 2019: A systematic scoping review","volume":"12","author":"AJ Eggleston","year":"2022","journal-title":"BMJ Open"},{"key":"pmed.1004405.ref107","unstructured":"Concept Foundation. Accelerating innovation for mothers\u2014AIM Gender. 2023 [cited 2023 Nov 10]. Available from: https:\/\/www.conceptfoundation.org\/accelerating-innovation-for-mothers\/aim-gender\/."},{"key":"pmed.1004405.ref108","first-page":"S21","article-title":"Improving racial and ethnic equity in clinical trials enrolling pregnant and lactating individuals","volume":"63","author":"AF Louis-Jacques","year":"2023","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"pmed.1004405.ref109","doi-asserted-by":"crossref","first-page":"e0282088","DOI":"10.1371\/journal.pone.0282088","article-title":"Factors which influence ethnic minority women\u2019s participation in maternity research: A systematic review of quantitative and qualitative studies","volume":"18","author":"H Lovell","year":"2023","journal-title":"PLoS ONE"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:44:09Z","timestamp":1717091049000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":109,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004405","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}